Top Stock Picks from Wall Street AnalystsTop Stock Picks from Wall Street Analysts According to leading Wall Street analysts, the following three stocks are considered “Strong Buys”: 1. Praxis Precision Medicines (PRAX): A biopharmaceutical company focused on developing treatments for central nervous system disorders. Piper Sandler analyst Yasmeen Rahimi has assigned a Buy rating with a price target of $270 per share. Top analysts unanimously recommend a Buy with an implied upside of 193% over the next 12 months. 2. Golden Entertainment (GDEN): A gaming company that received a reiterated Buy rating from Truist Financial analyst Barry Jonas. Jonas lowered the price target from $43 to $40, but all five top analysts maintain a Buy recommendation. Their 12-month price targets indicate a potential upside of 32%. 3. Roivant Sciences (ROIV): A commercial-stage biopharmaceutical company. Piper Sandler analyst Allison Bratzel has maintained a Buy rating with a price target of $22 per share. Top analysts unanimously assign a Buy rating, implying an upside of 62% over the next 12 months. Identifying Top Analysts TipRanks rates financial analysts based on the accuracy and profitability of their reviews. Five-star analysts have demonstrated exceptional performance over time. Disclaimer Before adding any stock to your portfolio, it’s crucial to conduct thorough research and consider your own investment goals and risk tolerance.
Which stocks are the best to buy right now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock has recently received a new Buy rating and also has significant upside.
To find more stocks like this, check out TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all the stocks recently reviewed by top-ranking analysts.
Here are today’s top stock picks, according to analysts. Click on a ticker to research the stock in depth before you decide to add it to your portfolio.
Praxis Precision Medicines (PRAX) – This is a clinical-stage biopharmaceutical company developing therapies for central nervous system disorders. Today, Piper Sandler analyst Yasmeen Rahimi rated the stock with a Buy rating and a price target of $270 per share. Over the past three months, all seven Top Analysts covering the stock have rated it Buy. Together, their 12-month price targets imply an upside of about 193%.
Golden Entertainment (GDEN) – This is an American gaming company. Yesterday, Truist Financial analyst Barry Jonas reiterated a Buy rating on the stock, but lowered the price target from $43 to $40. Over the past three months, all five Top Analysts covering the stock have given it a Buy rating. Together, their 12-month price targets imply an upside of about 32%.
Roivant sciences (ROIV) – Roivant Sciences is a commercial-stage biopharmaceutical company. Yesterday, Piper Sandler analyst Allison Bratzel maintained a Buy rating on the stock with a price target of $22 per share. Over the past three months, all four Top Analysts covering the stock have given it a Buy rating. Together, their 12-month price targets imply an upside of about 62%.
Who are the best analysts?
TipRanks ranks financial analysts based on the success rates of their reviews and the average return on each of their reviews. The Top Analysts have each earned a five-star rating, thanks to the accuracy and profitability of their reviews over time.
View real-time analyst rankings and learn more about the performance of top analysts on TipRanks’ Top Wall Street Analysts page.
Revelation
